selected publications
-
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
Blood.
2017
Academic Article
GET IT
Times cited: 30 -
Splicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1.
PloS one.
2017
Academic Article
GET IT
Times cited: 11 -
Genetic drivers of vulnerability and resistance in relapsed acute lymphoblastic leukemia.
Proceedings of the National Academy of Sciences of the United States of America.
2016
Comment
GET IT
Times cited: 6 -
Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
PloS one.
2011
Academic Article
GET IT
Times cited: 3 -
Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950).
2010
Academic Article
GET IT
Times cited: 17 -
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.
Journal of the National Cancer Institute.
2010
Academic Article
GET IT
Times cited: 38 -
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.
The Journal of clinical investigation.
2009
Academic Article
GET IT
Times cited: 48 -
Relapse after allogeneic hematopoietic cell therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 75 -
NOD2 regulates hematopoietic cell function during graft-versus-host disease.
The Journal of experimental medicine.
2009
Academic Article
GET IT
Times cited: 81 -
Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.
Blood.
2009
Academic Article
GET IT
Times cited: 14 -
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
Blood.
2008
Academic Article
GET IT
Times cited: 20 -
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease.
Blood.
2008
Academic Article
GET IT
Times cited: 46 -
Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation.
Blood.
2008
Academic Article
GET IT
Times cited: 12 -
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.
Nature biotechnology.
2008
Academic Article
GET IT
Times cited: 83 -
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950).
2007
Academic Article
GET IT
Times cited: 14 -
Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity.
Blood.
2007
Academic Article
GET IT
Times cited: 22 -
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.
Nature medicine.
2006
Academic Article
GET IT
Times cited: 142 -
Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.
Journal of immunology (Baltimore, Md. : 1950).
2006
Academic Article
GET IT
Times cited: 145 -
Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.
Blood.
2005
Academic Article
GET IT
Times cited: 77